March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 26, 2025

FDA Approves Cabozantinib for pNET and epNET

Today, the FDA approved the tyrosine kinase inhibitor cabozantinib (Cabometyx) for adult and pediatric patients aged 12 years and older with previously treated, unresectable, locally advanced or metas...

The ASCO Post

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 18, 2025

High-Risk Rhabdomyosarcoma: Long-Term Outcomes With Maintenance Chemotherapy

Long-term follow-up of the European Paediatric Soft Tissue Sarcoma Study Group RMS2005 trial was recently reported.

The ASCO Post

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 11, 2025

Doctors Never Truly Vacation, Study Reveals

"Organizations should implement strategies to minimize clinical tasks during PTO."

Conexiant

March 10, 2025

Childhood Cancer Survivors Face Higher Risk of Suicidal Ideation

"The prevalence of mental health conditions is higher among CCSs compared with the general population."

Conexiant

March 10, 2025

Clonal and Subclonal Pathogenic Alterations at Diagnosis in High-Risk Neuroblastoma

A recent study identified the spectrum and clinical significance of clonal and subclonal pathogenic alterations in high-risk neuroblastoma.

The ASCO Post

March 06, 2025

Early Research Finds Aspirin May Block Cancer Spread by Boosting Immune Response

Preclinical study demonstrates that aspirin may prevent cancer metastasis by inhibiting platelet-produced TXA2, which normally suppresses T-cell immunity against spreading cancer cells.

Conexiant